Beyfortus 50 mg/0.5 mL single-dose pre-filled syringe Images
Generic Name: nirsevimab
This medication has been identified as Beyfortus 50 mg/0.5 mL single-dose pre-filled syringe. It is supplied by AstraZeneca.
Beyfortus is used in the treatment of RSV Vaccination and Immunization; RSV and belongs to the drug class antiviral monoclonal antibodies. Beyfortus 50 mg/0.5 mL single-dose pre-filled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Beyfortus
- Generic Name
- nirsevimab
- Strength
- 50 mg/0.5 mL single-dose pre-filled syringe
- Availability
- Prescription only
- Drug Class
- Antiviral monoclonal antibodies
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 49281-0575
See also:
Arexvy
Arexvy is a vaccine used to prevent respiratory syncytial virus (RSV) lower respiratory tract ...
Abrysvo
Abrysvo is a vaccine used to prevent respiratory syncytial virus (RSV) lower respiratory tract ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
mRESVIA
mRESVIA is a vaccine used to immunize adults aged 60 years and older against lower respiratory ...
Synagis
Synagis is used to prevent lung disease caused by respiratory syncytial virus. Learn about side ...
Enflonsia
Enflonsia is an FDA-approved medication used to prevent respiratory syncytial virus (RSV) lower ...
Rsv vaccine, pref a-pref b, recombinant
Respiratory Syncytial Virus (RSV) vaccines (Abrysvo, Arexvy, mResvia) are used to help reduce the ...
More about Beyfortus (nirsevimab)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral monoclonal antibodies
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.